Physical activity, obesity and sedentary behavior in cancer etiology: epidemiologic evidence and biologic mechanisms.

Friedenreich CM, Ryder-Burbidge C, McNeil J. · 2021

Read Physical activity, obesity and sedentary behavior in cancer etiology: epidemiologic evidence and biologic mechanisms. by Friedenreich CM, Ryder-Burbidge C, McNeil J. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7931121.txt.

Introduction

Friedenreich and co-authors present a review of movement, weight, and sitting time in the causes of cancer. An estimated 4 in 10 cancers can be prevented through changeable risk factors. The review gathers the population evidence on three linked habits: physical activity, sedentary behaviour, and obesity. It asks how strongly each one shifts cancer risk.

The authors summarise what large studies show across cancer types. They then explore the biology that may explain the links. Hormones made in the body are one route. Insulin sensitivity is another. Chronic inflammation forms a third path. Together these systems can raise or lower the chance that a tumour starts. The review gives public health planners a clear view of the stakes. It also shows where the proof is firm and where it is thin.

Catalog record

CREATORFriedenreich CM, Ryder-Burbidge C, McNeil J.
YEAR2021
COLLECTIONPAPERS
FORMATTXT
FILE SIZE42 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7931121

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Physical activity, obesity and sedentary behavior in cancer etiology: epidemiologic evidence and biologic mechanisms By Christine M Friedenreich, Charlotte Ryder‐Burbidge, Jessica McNeil Published in: Molecular Oncology DOI: 10.1002/1878-0261.12772 ABSTRACT An estimated 4 in 10 cancers are preventable through modifiable risk factors. This review summarizes the epidemiologic evidence linking physical activity, sedentary behavior, and obesity with cancer risk. We explore the possible biologic mechanisms underpinning the associations between these lifestyle factors and cancer incidence, including effects on endogenous sex steroids and metabolic hormones, insulin sensitivity, and chronic inflammation. Keywords: chronic inflammation, hormone, metabolism, obesity, physical activity, sedentary behavior AbbreviationsBETABreast cancer and Exercise Trial in AlbertaBMIbody mass indexCRPC‐reactive proteinIGFinsulin growth factorIGFBPinsulin growth factor‐binding proteinIL‐1βinterleukin‐1 βIL‐6interleukin‐6METmetabolic equivalents of taskPAGAPhysical Activity Guidelines for AmericansRCTrandomized controlled trialROSreactive oxygen speciesRRrelative riskSAAserum amyloid ASHBGsex hormone‐binding globulinTNF‐αtumor necrosis factor‐αUVultravioletWCRF/AICRWorld Cancer Research Fund/American Institute for Cancer Research INTRODUCTION The epidemiologic evidence base regarding the etiologic role for physical activity, sedentary behavior, and obesity in cancer incidence has been evolving rapidly over the past three decades, and there is now convincing evidence for these associations. Research has also been conducted to examine the underlying biologic mechanisms that could explain how these risk factors are associated with increased cancer risk. Estimates of the population burden associated with modifiable risk factors and cancer incidence have demonstrated that 30–40% of cancers are potentially preventable [1, 2, 3, 4] and that some of the major risk factors associated with cancer include physical inactivity, sedentary behavior, and obesity. Furthermore, there is a considerable economic cost that could be avoided by decreasing the prevalence of these modifiable risk factors [5]. At present, the global prevalence of inactivity as defined by low levels of physical activity, sedentary behavior, and obesity is high [6, 7]. Given that these risk factors are modifiable, there is considerable potential to reduce the global burden of cancer through interventions targeting these factors. The aim of this paper was to provide an overview of the current epidemiologic evidence associating physical activity, sedentary behavior, and obesity with cancer incidence, and the hypothesized biologic mechanisms that are likely to connect these factors with cancer risk. The paper concludes with recommendations for future epidemiologic research on these topics to address some of the remaining knowledge gaps. PHYSICAL ACTIVITY AND CANCER INCIDENCE Physical activity, defined as any bodily movement produced by skeletal muscles that requires energy expenditure, has been characterized and investigated in epidemiologic studies by the domain in which the activity is achieved (e.g., occupational, recreational, household, and transport activity), the volume of the activity (as measured by the frequency, duration, and intensity), and the time periods when the activity was done (ranging from current to lifetime activity). To date, over 500 observational epidemiologic studies have examined some aspect of the association between physical activity and cancer incidence. Most recently, this evidence has been evaluated and summarized for the Physical Activity Guidelines for Americans (PAGA) 2018 Report as well as by the World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) as part of their recommendations on physical activity for cancer risk reduction [8, 9]. These reviews of the evidence, as well as multiple systematic reviews and meta‐analyses on this topic, have concluded that there is some evidence for a reduced risk of 11 different cancer sites when comparing the highest to the lowest levels of physical activity (Table 1). [Table: Summary of the observational epidemiologic evidence on the association between physical activity and cancer risk by cancer site. Summary evidence for the dose–response effect, biologic plausibility, and overall classification of evidence was acquired from the 2018 Physical Activity Guidelines Advisory Committee [8] and McTiernan et al. [10]. Risk reduction estimates were acquired from McTiernan et al. [10] and meta‐analyses previously conducted by the authors.] Specifically, there is strong evidence that physical activity reduces the risk of bladder, breast, colon, endometrial, esophageal adenocarcinoma, and gastric cancers. There is moderate evidence for an association between higher levels of physical activity with lower occurrence of renal, ovarian, pancreatic, and lung cancers. Nevertheless, confounding by tobacco smoking may exist for lung cancer. Limited evidence exists for an association between increased physical activity and decreased risk of prostate cancer. There is limited evidence for an increased risk of melanoma with higher physical activity levels. However, uncontrolled confounding by ultraviolet (UV) exposure in these studies may explain this possible increased risk. The evidence for an association between physical activity and other cancer sites remains insufficient. The magnitude of the decreased risk associated with higher levels of physical activity ranges from about 10–25% for most of these cancer sites [10]. A dose–response association between increasing levels of physical activity and specific cancer risk is evident for several cancer sites but the methods for measuring and categorizing physical activity levels across epidemiologic studies have been inconsistent which precludes any definitive conclusions regarding the exact volume of physical activity that provide given levels of effect. Furthermore, insufficient evidence is available to determine if the association between physical activity and cancer risk varies by domain or type (i.e., aerobic versus resistance exercise) of physical activity [8]. Limited information exists at present on how the association between physical activity and cancer varies by cancer subtypes. With respect to how physical activity varies across population subgroups, there is evidence that being physically active is equally beneficial for men and women. Moreover, some evidence suggests that lifelong activity is particularly beneficial. However, activity later in life can also reduce cancer risk (e.g., activity done after menopause has been shown to reduce breast cancer risk irrespective of premenopausal activity) [8]. There is also evidence that physical activity benefits are comparable across all racial and ethnic groups. SEDENTARY BEHAVIOR AND CANCER INCIDENCE Sedentary behaviors include all waking activities with an energy expenditure ≤ 1.5 metabolic equivalents of task (METs) performed in the sitting, reclining, or lying postures (e.g., watching television, working at a computer, sitting in a vehicle) [11]. It is important to recognize that high amounts of sedentary time are not synonymous with low levels of physical activity [12]. For example, an individual may achieve or exceed physical activity recommendations but also spend long, uninterrupted time sitting at a work computer and/or watching television at home. Conversely, a person may accumulate small amounts of sedentary time over a 24‐h period as a result of a physically demanding job, but also have no or low levels of recreational physical activity. Therefore, it is important to consider both the amount of time dedicated to physical activity and time spent in sedentary behavior for cancer prevention. The AICR developed an educational infographic to illustrate the importance of making time for physical activity and breaking up sedentary time for cancer prevention [13]. A recent update published by the 2018 PAGA Committee reported that there is moderate evidence to suggest that high levels of sedentary time are associated with an increased risk of colon, endometrial, and lung cancers, with limited evidence for a dose–response relation [14]. Recently published reviews also corroborate these findings [12, 15]. Specifically, high versus low levels of sedentary time were consistently associated with a range in relative risks (RR) of 1.28–1.44 for colon cancer, 1.28–1.36 for endometrial cancer, and 1.21–1.27 for lung cancer (Table 2). [Table: Summary of the observational

Read the complete text